CAMBRIA-1:ER+/HER2- Early Stage Breast Cancer being treated with Endocrine Therapy after Surgery
Clinical Trial Grant
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 18, 2024
End Date
May 31, 2028
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 18, 2024
End Date
May 31, 2028